RespireRx Pharmaceuticals Inc (RSPI)

[K-G]

Yes, we should all obviously get back on our meds... Personally, I'm not at all surprised in their needing some time to go through the data set. It seems like it would be a pretty complex set to analyze, especially with the small number of subjects. They would want to do more than just look at event frequency, and may want to try to separate the types of SA events, look at other systemic effects on the sleep cycle, and check any number of suspected correlations.
I know Neuro did not agree with my interpretation of Mark's comments, but my mind immediately factored in a week or two after receipt of 'The Data' before anything would be released. If it were me, I would want to be really careful about the release of any conclusions from this study that could over- or under- state the efficaciousness of the compound, or the impact of any side effects.
Just my 2 cents worth - or was that 2 shares worth?